ECSP066948A - Benzoxazinas para el tratamiento de enfermedades de las vías respiratorias - Google Patents

Benzoxazinas para el tratamiento de enfermedades de las vías respiratorias

Info

Publication number
ECSP066948A
ECSP066948A EC2006006948A ECSP066948A ECSP066948A EC SP066948 A ECSP066948 A EC SP066948A EC 2006006948 A EC2006006948 A EC 2006006948A EC SP066948 A ECSP066948 A EC SP066948A EC SP066948 A ECSP066948 A EC SP066948A
Authority
EC
Ecuador
Prior art keywords
treatment
benzoxazines
respiratory road
road diseases
diseases
Prior art date
Application number
EC2006006948A
Other languages
English (en)
Inventor
Sabine Pestel
Klaus Rudolf
Philipp Lustenberger
Thierry Bouyssou
Frank Buettner
Ingo Konetzki
Andreas Schnapp
Hermann Schollenberger
Kurt Schromm
Claudia Heine
Christoph Hoenke
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of ECSP066948A publication Critical patent/ECSP066948A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

La presente invención se refiere al uso de los compuestos de la fórmula general 1 en donde los radicales R1, R2 y R3 pueden tener los significados mencionados en las reivindicaciones y en la memoria descriptiva, para la preparación de un medicamento para el tratamiento de enfermedades de las vías respiratorias.
EC2006006948A 2004-04-22 2006-10-23 Benzoxazinas para el tratamiento de enfermedades de las vías respiratorias ECSP066948A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004019539A DE102004019539A1 (de) 2004-04-22 2004-04-22 Neue Arzneimittel zur Behandlung von Atemwegserkrankungen

Publications (1)

Publication Number Publication Date
ECSP066948A true ECSP066948A (es) 2006-12-20

Family

ID=34966948

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2006006948A ECSP066948A (es) 2004-04-22 2006-10-23 Benzoxazinas para el tratamiento de enfermedades de las vías respiratorias

Country Status (20)

Country Link
EP (1) EP1765355B1 (es)
JP (1) JP2007533684A (es)
KR (2) KR20130042662A (es)
CN (1) CN1946406A (es)
AU (1) AU2005235420C1 (es)
BR (1) BRPI0510084A (es)
CA (1) CA2559700C (es)
DE (1) DE102004019539A1 (es)
DK (1) DK1765355T3 (es)
EA (1) EA012045B1 (es)
EC (1) ECSP066948A (es)
ES (1) ES2403184T3 (es)
IL (1) IL177663A (es)
NO (1) NO20065061L (es)
NZ (1) NZ551272A (es)
PL (1) PL1765355T3 (es)
SG (1) SG152233A1 (es)
UA (1) UA85707C2 (es)
WO (1) WO2005102350A1 (es)
ZA (1) ZA200606547B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102004024452A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation von Betaagonisten
KR101360803B1 (ko) 2005-08-15 2014-02-11 베링거 인겔하임 인터내셔날 게엠베하 베타모방제의 제조방법
BRPI0618370A2 (pt) * 2005-11-09 2011-08-30 Boehringer Ingelheim Int formulação aerossol de medicamento, uso do mesmo e kit de inalação
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
EP2231642B1 (en) 2008-01-11 2013-10-23 Novartis AG Pyrimidines as kinase inhibitors
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
US8637516B2 (en) 2010-09-09 2014-01-28 Irm Llc Compounds and compositions as TRK inhibitors
AU2012220572A1 (en) 2011-02-25 2013-08-29 Irm Llc Compounds and compositions as trk inhibitors
WO2014108449A1 (en) 2013-01-08 2014-07-17 Atrogi Ab A screening method, a kit, a method of treatment and a compound for use in a method of treatment
JP2019536812A (ja) 2016-12-12 2019-12-19 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング オロダテロールとの同時投与による間質性肺疾患の処置方法に使用するためのニンテダニブ
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201903832D0 (en) 2019-03-20 2019-05-01 Atrogi Ab New compounds and methods
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses
EP4651867A1 (en) 2023-01-20 2025-11-26 Atrogi AB Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting
GB202302225D0 (en) 2023-02-16 2023-04-05 Atrogi Ab New medical uses
GB202303229D0 (en) 2023-03-06 2023-04-19 Atrogi Ab New medical uses
GB202403169D0 (en) 2024-03-05 2024-04-17 Atrogi Ab New medical uses
WO2025238248A1 (en) 2024-05-17 2025-11-20 Atrogi Ab USE OF β2-ADRENERGIC RECEPTOR AGONISTS IN TREATING MUSCLE WASTING

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
AU5629301A (en) * 2000-04-27 2001-11-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel, slow-acting betamimetics, a method for their production and their use as medicaments
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung

Also Published As

Publication number Publication date
KR101338947B1 (ko) 2013-12-10
WO2005102350A1 (de) 2005-11-03
AU2005235420B2 (en) 2010-10-28
EA012045B1 (ru) 2009-08-28
KR20130042662A (ko) 2013-04-26
CN1946406A (zh) 2007-04-11
KR20070054599A (ko) 2007-05-29
DE102004019539A1 (de) 2005-11-10
EA200601837A1 (ru) 2007-04-27
EP1765355B1 (de) 2013-03-06
SG152233A1 (en) 2009-05-29
DK1765355T3 (da) 2013-04-08
ZA200606547B (en) 2008-04-30
EP1765355A1 (de) 2007-03-28
IL177663A0 (en) 2006-12-31
BRPI0510084A (pt) 2007-10-16
NO20065061L (no) 2006-11-07
IL177663A (en) 2014-04-30
JP2007533684A (ja) 2007-11-22
PL1765355T3 (pl) 2013-08-30
ES2403184T3 (es) 2013-05-16
UA85707C2 (ru) 2009-02-25
AU2005235420C1 (en) 2011-02-24
CA2559700A1 (en) 2005-11-03
NZ551272A (en) 2010-10-29
AU2005235420A1 (en) 2005-11-03
CA2559700C (en) 2013-06-11

Similar Documents

Publication Publication Date Title
ECSP077331A (es) Nuevos betamiméticos para el tratamiento de enfermedades de vías respiratorias
ECSP055774A (es) Nuevo medicamento para el tratamiento de la enfermedad pulmonar obstructiva crónica
UY28369A1 (es) Agentes terapéuticos
UY27755A1 (es) Nuevas composiciones farmacéuticas basadas en anticolinérgicos e inhibidores.
CY1113323T1 (el) Ενωσεις τετραϋδροφουρο[3,4-d]διοξολανιου για χρηση στη θεραπεια ιικων μολυνσεων και καρκινου
ECSP109903A (es) Derivados de pirazinona y su uso en el tratamiento de enfermedades pulmonares
DOP2006000169A (es) Inhibidores espiropiperidina de beta-secretasa para el tratamiento de la enfermedad de alzheimer
UY28376A1 (es) Agentes terapéuticos
CR8649A (es) Derivados de formamidina para el tratamiento de enfermedades
UY27714A1 (es) 2 - heteroaril - pirimidinas inhibidoras de cdk, su preparación y su uso como medicamentos.
UY27226A1 (es) Pirazolopirimidinas como agentes terapéuticos
GT200400116A (es) Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades.
CR10419A (es) Derivados de Pirazolo [3,4-D]-Pirimidina útiles para tratar trastornos respiratorios
CR6726A (es) Compuestos azapoliciclicos condensados con arilo
DK1819227T3 (da) Farmaceutisk formulering af decitabin
SE0401342D0 (sv) Therapeutic compounds
UY29253A1 (es) 3-amino-pirazol(3,4b)piridinas como inhibidores de proteintirosinquinasas, su preparación y uso como medicamento
UY28144A1 (es) Agentes terapéuticos
AR077478A2 (es) Derivados de oxindol sustituido medicamentos que los comprenden y uso de los mismos
ECSP066947A (es) Combinaciones farmacológicas que contienen benzoxazina para el tratamiento de enfermedades de las vías respiratorias
ECSP055964A (es) Heterociclil-3-sulfonilindazoles como ligandos de 5-hidroxitriptamina-6
UA85707C2 (ru) Бензоксазины для лечения заболеваний дыхательных путей
UY28377A1 (es) Agentes terapeuticos
PA8627001A1 (es) Compuestos para el tratamiento de enfermedades
ECSP099506A (es) Derivados de 2-quinolinona y 2 quinoxalinona y su utilización como agentes anti bacterianos